These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 16081681)

  • 1. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase.
    Salter-Cid LM; Wang E; O'Rourke AM; Miller A; Gao H; Huang L; Garcia A; Linnik MD
    J Pharmacol Exp Ther; 2005 Nov; 315(2):553-62. PubMed ID: 16081681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
    O'Rourke AM; Wang EY; Miller A; Podar EM; Scheyhing K; Huang L; Kessler C; Gao H; Ton-Nu HT; Macdonald MT; Jones DS; Linnik MD
    J Pharmacol Exp Ther; 2008 Feb; 324(2):867-75. PubMed ID: 17993604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of semicarbazide-sensitive amine oxidase (SSAO) inhibitors with anti-inflammatory activity.
    Wang EY; Gao H; Salter-Cid L; Zhang J; Huang L; Podar EM; Miller A; Zhao J; O'rourke A; Linnik MD
    J Med Chem; 2006 Apr; 49(7):2166-73. PubMed ID: 16570912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular adhesion protein-1 plays an important role in postischemic inflammation and neuropathology in diabetic, estrogen-treated ovariectomized female rats subjected to transient forebrain ischemia.
    Xu HL; Salter-Cid L; Linnik MD; Wang EY; Paisansathan C; Pelligrino DA
    J Pharmacol Exp Ther; 2006 Apr; 317(1):19-29. PubMed ID: 16339390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SSAO inhibitors suppress hepatocellular tumor growth in mice.
    Li R; Li H; Luo HJ; Lin ZX; Jiang ZW; Luo WH
    Cell Immunol; 2013; 283(1-2):61-9. PubMed ID: 23850964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The discovery and development of selective 3-fluoro-4-aryloxyallylamine inhibitors of the amine oxidase activity of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1).
    Foot JS; Deodhar M; Turner CI; Yin P; van Dam EM; Silva DG; Olivieri A; Holt A; McDonald IA
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3935-40. PubMed ID: 22595173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzylamine and methylamine, substrates of semicarbazide-sensitive amine oxidase, attenuate inflammatory response induced by lipopolysaccharide.
    Lin Z; Li H; Luo H; Zhang Y; Luo W
    Int Immunopharmacol; 2011 Aug; 11(8):1079-89. PubMed ID: 21414430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase.
    Langford SD; Trent MB; Balakumaran A; Boor PJ
    Toxicol Appl Pharmacol; 1999 Mar; 155(3):237-44. PubMed ID: 10079209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origins of serum semicarbazide-sensitive amine oxidase.
    Stolen CM; Yegutkin GG; Kurkijärvi R; Bono P; Alitalo K; Jalkanen S
    Circ Res; 2004 Jul; 95(1):50-7. PubMed ID: 15178639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitor sensitivity of human serum and vascular semicarbazide-sensitive amine oxidases.
    Mészáros Z; Csányi A; Vallus G; Szombathy T; Karádi I; Magyar K
    Neurobiology (Bp); 2000; 8(2):215-23. PubMed ID: 11061216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in atherogenesis in KKAy diabetic mice fed with high cholesterol diet.
    Yu PH; Wang M; Deng YL; Fan H; Shira-Bock L
    Diabetologia; 2002 Sep; 45(9):1255-62. PubMed ID: 12242458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in lipopolysaccharide-induced pulmonary inflammation.
    Yu PH; Lu LX; Fan H; Kazachkov M; Jiang ZJ; Jalkanen S; Stolen C
    Am J Pathol; 2006 Mar; 168(3):718-26. PubMed ID: 16507887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine oxidase and semicarbazide sensitive amine oxidase activities in normal and inflamed human dental pulp.
    Vavilova T; Ostrovskaya I; Axenova L; Buneeva O; Medvedev A
    Med Sci Monit; 2009 Oct; 15(10):BR289-292. PubMed ID: 19789505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues.
    Kinemuchi H; Sugimoto H; Obata T; Satoh N; Ueda S
    Neurotoxicology; 2004 Jan; 25(1-2):325-35. PubMed ID: 14697907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of semicarbazide-sensitive amine oxidase expression by tumor necrosis factor-alpha in adipocytes: functional consequences on glucose transport.
    Mercier N; Moldes M; El Hadri K; Fève B
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1197-208. PubMed ID: 12604697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1: a patent survey.
    Dunkel P; Balogh B; Meleddu R; Maccioni E; Gyires K; Mátyus P
    Expert Opin Ther Pat; 2011 Sep; 21(9):1453-71. PubMed ID: 21675926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
    Visentin V; Bour S; Boucher J; Prévot D; Valet P; Ordener C; Parini A; Carpéné C
    Eur J Pharmacol; 2005 Oct; 522(1-3):139-46. PubMed ID: 16202994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glitazones inhibit human monoamine oxidase but their anti-inflammatory actions are not mediated by VAP-1/semicarbazide-sensitive amine oxidase inhibition.
    Carpéné C; Bizou M; Tréguer K; Hasnaoui M; Grès S
    J Physiol Biochem; 2015 Sep; 71(3):487-96. PubMed ID: 25572340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PXS-4681A, a potent and selective mechanism-based inhibitor of SSAO/VAP-1 with anti-inflammatory effects in vivo.
    Foot JS; Yow TT; Schilter H; Buson A; Deodhar M; Findlay AD; Guo L; McDonald IA; Turner CI; Zhou W; Jarolimek W
    J Pharmacol Exp Ther; 2013 Nov; 347(2):365-74. PubMed ID: 23943052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications.
    Stolen CM; Madanat R; Marti L; Kari S; Yegutkin GG; Sariola H; Zorzano A; Jalkanen S
    FASEB J; 2004 Apr; 18(6):702-4. PubMed ID: 14977883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.